Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

NovaBay Pharmaceuticals, Inc. NBY

Set alert

Price alert · NBY

All alert types
1.47 USD 0.00 0.00%

As of May 22, 12:37 PM ET

Bid
1.93 × 300
Ask
1.97 × 200
1.47 Day range 1.47
0.36 52-week range 9.10
YTD
-94.79%
1 year
-47.32%
Open
1.47
Prev close
1.47
Mkt cap
2.52M
Vol
86.83K
Avg vol
476.87K
EPS
-74.61
P/E
0.00
Div yield
0.00%
More statistics
Low
1.47
High
1.47
Forward P/E
-0.63
Beta
0.00
Short ratio
0.07
Inst. own
2.58%
Dividend
0.00
Ex-div date
50-d avg
0.6314
200-d avg
1.85
1y target
3.73

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for NBY has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

2.26 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -7.4×
FY 2016: -95.5×FY 2017: -199×FY 2018: -49.9×FY 2019: -33.0×FY 2020: -55.4×FY 2021: -62.7×FY 2022: -4.8×FY 2023: -1.3×FY 2024: -5.9×FY 2025: -7.4×
FY 2016 5y median -5.9× FY 2025
P/S 0.0×
FY 2016: 106×FY 2017: 80.9×FY 2018: 21.9×FY 2019: 48.3×FY 2020: 61.5×FY 2021: 35.8×FY 2022: 3.6×FY 2023: 2.0×FY 2024: 5.2×FY 2025: 0.0×
FY 2016 5y median 3.6× FY 2025
P/B -7.2×
FY 2016: 177×FY 2017: 569×FY 2018: 55.4×FY 2019: 328×FY 2020: 49.6×FY 2021: 35.9×FY 2022: 4.9×FY 2023: 6.5×FY 2024: -396×FY 2025: -7.2×
FY 2016 5y median 4.9× FY 2025
P/FCF -19.5×
FY 2016: -102×FY 2017: -226×FY 2018: -48.9×FY 2019: -40.1×FY 2020: -129×FY 2021: -39.5×FY 2022: -7.6×FY 2023: -5.0×FY 2024: -9.8×FY 2025: -19.5×
FY 2016 5y median -9.8× FY 2025
EV/EBITDA -21.1×
FY 2016: -115×FY 2017: -204×FY 2018: -35.7×FY 2019: -33.8×FY 2020: -94.1×FY 2021: -40.9×FY 2022: -6.7×FY 2023: -5.1×FY 2024: -8.8×FY 2025: -21.1×
FY 2016 5y median -8.8× FY 2025
EV/Sales 0.0×
FY 2016: 105×FY 2017: 80.7×FY 2018: 21.7×FY 2019: 47.9×FY 2020: 60.4×FY 2021: 35.1×FY 2022: 3.3×FY 2023: 2.0×FY 2024: 5.4×FY 2025: 0.0×
FY 2016 5y median 3.3× FY 2025
FCF Yield -5.1%
FY 2016: -1.0%FY 2017: -0.4%FY 2018: -2.0%FY 2019: -2.5%FY 2020: -0.8%FY 2021: -2.5%FY 2022: -13.2%FY 2023: -20.0%FY 2024: -10.2%FY 2025: -5.1%
FY 2016 5y median -10.2% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 79.3%FY 2017: 84.7%FY 2018: 88.0%FY 2019: 73.7%FY 2020: 60.0%FY 2021: 63.8%FY 2022: 54.0%FY 2023: 58.2%FY 2024: 66.3%FY 2025: 0.0%
FY 2016 5y median 58.2% FY 2025
Operating Margin 0.0%
FY 2016: -92.3%FY 2017: -40.1%FY 2018: -62.9%FY 2019: -142.4%FY 2020: -64.7%FY 2021: -86.8%FY 2022: -100.1%FY 2023: -39.2%FY 2024: -59.7%FY 2025: 0.0%
FY 2016 5y median -59.7% FY 2025
Net Margin 0.0%
FY 2016: -110.5%FY 2017: -40.6%FY 2018: -52.3%FY 2019: -146.4%FY 2020: -111.1%FY 2021: -57.1%FY 2022: -73.6%FY 2023: -92.2%FY 2024: -73.8%FY 2025: 0.0%
FY 2016 5y median -73.6% FY 2025
ROE 97.0%
FY 2016: -185.2%FY 2017: -285.4%FY 2018: -132.1%FY 2019: -992.6%FY 2020: -89.6%FY 2021: -57.3%FY 2022: -100.5%FY 2023: -290.9%FY 2024: 5599.2%FY 2025: 97.0%
FY 2016 5y median -57.3% FY 2025
ROIC -90.5%
FY 2016: -99.3%FY 2017: -143.4%FY 2018: -142.7%FY 2019: -103.6%FY 2020: -50.1%FY 2021: -42.5%FY 2022: -114.5%FY 2023: -64.2%FY 2024: -378.4%FY 2025: -90.5%
FY 2016 5y median -90.5% FY 2025
ROA -245.1%
FY 2016: -85.5%FY 2017: -73.4%FY 2018: -69.9%FY 2019: -86.1%FY 2020: -72.4%FY 2021: -24.3%FY 2022: -64.7%FY 2023: -106.7%FY 2024: -211.0%FY 2025: -245.1%
FY 2016 5y median -106.7% FY 2025

Growth (YoY)

Revenue -100.0%
FY 2016: 171.6%FY 2017: 53.2%FY 2018: -31.4%FY 2019: -47.2%FY 2020: 50.5%FY 2021: 2.7%FY 2022: 41.2%FY 2023: -27.4%FY 2024: -6.4%FY 2025: -100.0%
FY 2016 FY 2025
Operating Income -29.9%
FY 2016: 47.7%FY 2017: 33.4%FY 2018: -7.7%FY 2019: -19.4%FY 2020: 31.6%FY 2021: -37.9%FY 2022: -62.7%FY 2023: 71.5%FY 2024: -42.3%FY 2025: -29.9%
FY 2016 FY 2025
EPS (diluted) -651.0%
FY 2016: -50.9%FY 2017: 43.5%FY 2018: 4.7%FY 2019: -5.2%FY 2020: 35.1%FY 2021: 52.3%FY 2022: -92.1%FY 2023: 60.8%FY 2024: 98.2%FY 2025: -651.0%
FY 2016 FY 2025
Free Cash Flow -62.5%
FY 2016: 34.2%FY 2017: 47.0%FY 2018: 13.8%FY 2019: -41.6%FY 2020: 40.3%FY 2021: -94.7%FY 2022: 26.8%FY 2023: 36.7%FY 2024: -21.2%FY 2025: -62.5%
FY 2016 FY 2025

Financial Health

Current Ratio 7.6×
FY 2016: 3.3×FY 2017: 1.8×FY 2018: 2.2×FY 2019: 1.6×FY 2020: 5.0×FY 2021: 3.8×FY 2022: 2.7×FY 2023: 1.7×FY 2024: 0.7×FY 2025: 7.6×
FY 2016 5y median 2.7× FY 2025
Quick Ratio 7.6×
FY 2016: 3.1×FY 2017: 1.7×FY 2018: 2.2×FY 2019: 1.6×FY 2020: 4.8×FY 2021: 2.9×FY 2022: 1.9×FY 2023: 1.0×FY 2024: 0.4×FY 2025: 7.6×
FY 2016 5y median 1.9× FY 2025
Debt / Equity -0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 4.2×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.2×FY 2023: 0.8×FY 2024: -13.0×FY 2025: -0.0×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 1.0×
FY 2016: 0.9×FY 2017: 0.4×FY 2018: 0.4×FY 2019: 0.3×FY 2020: 1.8×FY 2021: 0.8×FY 2022: 0.5×FY 2023: 0.1×FY 2024: -0.2×FY 2025: 1.0×
FY 2016 5y median 0.5× FY 2025
Interest Coverage -27.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -8.9×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -2.4×FY 2024: -6.5×FY 2025: -27.4×
FY 2016 5y median -2.4× FY 2025

Dividends

Dividend Yield 2.9%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 2.9%
FY 2016 5y median 0.0% FY 2025
Payout Ratio -21.8%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -21.8%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31